Promoting Heart and Kidney Health Through Community Screenings
Health and research company Care Access is rolling out its Heart & Kidney Health Screening initiative aimed at enhancing community knowledge about critical health risk factors. This initiative focuses particularly on a type of cholesterol known as lipoprotein(a), or Lp(a), which impacts one in five individuals and significantly heightens the risk of heart disease and stroke.
Understanding the Significance of Lp(a)
Despite its prevalence, many individuals are still unaware of their Lp(a) levels, largely due to the limited availability of testing options. Raising awareness of this genetic risk factor is essential, especially since there are no approved medications to lower Lp(a) levels, and lifestyle modifications such as diet and exercise do not affect it.
Details on the Health Screening Initiative
The Heart & Kidney Health Screening provides complimentary testing for Lp(a), along with assessments for other health concerns related to metabolism and kidney function. This screening is part of Care Access’s Future of Medicine program, which aims not only to offer crucial health insights but also to promote community participation in clinical research targeting Lp(a) and other health issues.
Core Components of the Future of Medicine Program
- No-Cost Testing: Residents can access no-cost screenings for heart and kidney health indicators, including Lp(a), to gain valuable insights into their health.
- Health Education: The program provides essential information regarding cardiovascular wellness and the role of clinical research in enabling improved medical treatments.
- Clinical Research Awareness: Care Access assists the community in identifying local clinical studies and encourages broader engagement in medical research.
Event Logistics and Community Engagement
Care Access will host the health screenings at a local venue. While walk-in participants are welcome, scheduling in advance is encouraged. This event is crafted to bridge the gap between community members and essential health services, fostering a proactive approach to managing heart health.
Expert Insight from Care Access
Dr. Sinikka Green, Medical Director at Care Access, emphasized the initiative's relevance: "The limited availability of testing for Lp(a) has been a concern in our field for too long. This program not only provides accessibility to necessary tests but also seeks to educate community members about the implications of elevated levels."
Additional Opportunities for Healthcare Providers
Care Access is extending an open invitation for physicians to collaborate in bringing these beneficial screenings to their patients. With over 200 research sites around the world, Care Access is dedicated to improving health access and resources in communities.
Commitment to Global Health Enhancement
Through the Future of Medicine initiative, Care Access strives to offer complimentary health screenings while disseminating information about ongoing research studies and health education services. They are committed to supporting local leaders in advocating for improved health and wellness in their communities.
Frequently Asked Questions
What is the purpose of the Health Screening Initiative?
The initiative aims to promote awareness of heart and kidney health risks, specifically focusing on Lp(a) testing.
How can community members participate in the screenings?
Residents can attend the health screenings, with the option to schedule an appointment for better service.
What is Lp(a), and why is it important?
Lp(a) is a type of cholesterol that significantly increases the risk of heart disease and stroke, but many are unaware of their levels.
How does Care Access contribute to community health?
Care Access provides no-cost health screenings, education about medical research, and opportunities for community involvement.
Are there any costs for the health screenings?
No, the health screenings are offered at no cost to participants, making essential health information accessible.
